• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA TCONS_00068220 通过调节上皮-间充质转化标志物 E-钙黏蛋白促进乳腺癌进展。

Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin.

机构信息

Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China (mainland).

Department of Breast and Thyroid Surgery, Hospital of Chinese Medicine of Taian City, Taian, Shandong, China (mainland).

出版信息

Med Sci Monit. 2021 Mar 15;27:e929832. doi: 10.12659/MSM.929832.

DOI:10.12659/MSM.929832
PMID:33716295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7976663/
Abstract

BACKGROUND Long noncoding RNAs (lncRNAs) play essential roles in the regulation of breast cancer development. We herein investigated the potential role of lncRNA TCONS_00068220 in breast cancer pathogenesis. MATERIAL AND METHODS The expression levels of TCONS_00068220 in breast cancer tissues were measured by qRT-PCR. Afterwards, TCONS_00068220 was (1) overexpressed in MCF-7 breast cancer cells, and (2) silenced in MDA-MB-231 cells. Then, CCK-8 and transwell assays were conducted to detect the impact of TCONS_00068220 on cell proliferation, migration, and invasion. The expression of the epithelial-mesenchymal transition (EMT) marker E-cadherin was detected by western blot assay after upregulation or downregulation of TCONS_00068220. RESULTS TCONS_00068220 was remarkably upregulated in breast cancer tissues compared with non-cancerous tissues. In addition, TCONS_00068220 level was significantly correlated with lymphatic metastasis, Ki67 index, clinical stage, and differentiation grade. All breast cancer cell lines displayed a higher expression level of TCONS_00068220 compared with the normal breast epithelial cell line MCF-10A. Furthermore, enhanced expression of TCONS_00068220 in MCF-7 cells promoted cell proliferation, migration, invasion, and EMT, whereas TCONS_00068220 knockdown in MDA-MB-231 cells led to the opposite results. E-cadherin was negatively regulated by TCONS_00068220 in both breast cancer tissues and cell lines. Finally, TCONS_00068220 regulated MCF-7 and MDA-MB-231 cell behaviors by downregulating E-cadherin. CONCLUSIONS TCONS_00068220 promotes breast cancer cell proliferation, migration, and invasion, while facilitating the process of EMT by interacting with E-cadherin and suppressing its expression. Therefore, it may potentially serve as an oncogene in breast cancer progression.

摘要

背景

长链非编码 RNA(lncRNA)在乳腺癌的发展中起着至关重要的调节作用。本研究旨在探讨 lncRNA TCONS_00068220 在乳腺癌发病机制中的潜在作用。

材料与方法

采用 qRT-PCR 检测乳腺癌组织中 TCONS_00068220 的表达水平。然后,在 MCF-7 乳腺癌细胞中转染 TCONS_00068220 过表达载体,在 MDA-MB-231 细胞中转染 TCONS_00068220 沉默载体。采用 CCK-8 法和 Transwell 实验检测 TCONS_00068220 对细胞增殖、迁移和侵袭的影响。通过上调或下调 TCONS_00068220 表达水平,采用 Western blot 检测上皮-间充质转化(EMT)标志物 E-钙黏蛋白的表达。

结果

与非癌组织相比,乳腺癌组织中 TCONS_00068220 表达明显上调。此外,TCONS_00068220 水平与淋巴转移、Ki67 指数、临床分期和分化程度显著相关。与正常乳腺上皮细胞系 MCF-10A 相比,所有乳腺癌细胞系均显示出更高的 TCONS_00068220 表达水平。此外,MCF-7 细胞中 TCONS_00068220 的表达增强促进了细胞增殖、迁移、侵袭和 EMT,而 MDA-MB-231 细胞中 TCONS_00068220 的敲低则导致相反的结果。在乳腺癌组织和细胞系中,E-钙黏蛋白受 TCONS_00068220 的负调控。最后,TCONS_00068220 通过下调 E-钙黏蛋白调节 MCF-7 和 MDA-MB-231 细胞的行为。

结论

TCONS_00068220 通过与 E-钙黏蛋白相互作用并抑制其表达,促进乳腺癌细胞的增殖、迁移和侵袭,同时促进 EMT 过程。因此,它可能是乳腺癌进展中的潜在癌基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/4902f4026152/medscimonit-27-e929832-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/31d7b029d941/medscimonit-27-e929832-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/8325a7d71399/medscimonit-27-e929832-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/4104fc1725a6/medscimonit-27-e929832-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/e365810817d9/medscimonit-27-e929832-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/a41c5ef27cc8/medscimonit-27-e929832-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/4902f4026152/medscimonit-27-e929832-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/31d7b029d941/medscimonit-27-e929832-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/8325a7d71399/medscimonit-27-e929832-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/4104fc1725a6/medscimonit-27-e929832-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/e365810817d9/medscimonit-27-e929832-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/a41c5ef27cc8/medscimonit-27-e929832-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/7976663/4902f4026152/medscimonit-27-e929832-g006.jpg

相似文献

1
Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin.长链非编码 RNA TCONS_00068220 通过调节上皮-间充质转化标志物 E-钙黏蛋白促进乳腺癌进展。
Med Sci Monit. 2021 Mar 15;27:e929832. doi: 10.12659/MSM.929832.
2
Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.长非编码 RNA GHET1 通过影响上皮间质转化促进人乳腺癌细胞的增殖、侵袭和迁移。
Cancer Biomark. 2018;22(3):565-573. doi: 10.3233/CBM-181250.
3
Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells.敲低长链非编码 RNA ZEB2NAT 抑制乳腺癌细胞中的上皮间质转化、转移和增殖。
Gene. 2021 Dec 30;805:145904. doi: 10.1016/j.gene.2021.145904. Epub 2021 Aug 19.
4
MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.微小RNA-372-3p通过激活Wnt信号通路促进乳腺癌的上皮-间质转化。
J BUON. 2018 Sep-Oct;23(5):1309-1315.
5
Down-regulation of lncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells.长链非编码 RNA Linc00152 的下调抑制了乳腺癌细胞的活力、侵袭、迁移和上皮间质转化,并逆转了其化疗耐药性。
Eur Rev Med Pharmacol Sci. 2018 May;22(10):3074-3084. doi: 10.26355/eurrev_201805_15067.
6
Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.MDA-MB-468人乳腺癌细胞体外增殖、异种移植生长及转移的上皮细胞需求:E-钙黏蛋白的致癌而非抑癌作用
Breast Cancer Res. 2017 Jul 27;19(1):86. doi: 10.1186/s13058-017-0880-z.
7
lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.长链非编码 RNA MIR503HG 作为一种肿瘤抑制因子,抑制膀胱癌中的细胞增殖、转移和上皮-间充质转化。
J Cell Biochem. 2019 Jun;120(6):10821-10829. doi: 10.1002/jcb.28373. Epub 2019 Jan 22.
8
Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.磷脂酰肌醇蛋白聚糖-3可诱导人乳腺癌细胞发生间充质向上皮转化。
Oncotarget. 2016 Sep 13;7(37):60133-60154. doi: 10.18632/oncotarget.11107.
9
LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.长链非编码RNA-SNHG7调节膀胱癌细胞的增殖、凋亡和侵袭 保障指南。 你提供的原文可能不太完整或表述有误,正常来说这样的内容作为一个句子结构不太合理,可能会影响准确理解和翻译。你可以检查一下原文是否准确。
J BUON. 2018 May-Jun;23(3):776-781.
10
LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.LncRNA DLEU1/miRNA-300/RAB22A 轴调控乳腺癌细胞的迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10410-10421. doi: 10.26355/eurrev_201912_19680.

引用本文的文献

1
LINC01305 and LAD1 Co-Regulate CTTN and N-WASP Phosphorylation, Mediating Cytoskeletal Reorganization to Promote ESCC Metastasis.LINC01305与LAD1共同调节CTTN和N-WASP磷酸化,介导细胞骨架重组以促进食管鳞状细胞癌转移。
Mol Carcinog. 2025 Apr;64(4):756-768. doi: 10.1002/mc.23885. Epub 2025 Jan 21.
2
PCSK9 promotes tumor cell proliferation and migration by facilitating CCL25 secretion in esophageal squamous cell carcinoma.在食管鳞状细胞癌中,前蛋白转化酶枯草溶菌素9(PCSK9)通过促进趋化因子配体25(CCL25)的分泌来促进肿瘤细胞增殖和迁移。
Oncol Lett. 2023 Oct 4;26(5):500. doi: 10.3892/ol.2023.14086. eCollection 2023 Nov.

本文引用的文献

1
miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines.miR-9-5p作为乳腺癌细胞系中雄激素受体通路的调节因子
Front Cell Dev Biol. 2020 Nov 12;8:579160. doi: 10.3389/fcell.2020.579160. eCollection 2020.
2
A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy.一个由九个长链非编码 RNA 组成的标志物可预测接受紫杉烷和蒽环类药物为基础的新辅助化疗的 HER2 阴性乳腺癌患者的远处无复发生存率。
Biochem Pharmacol. 2021 Jul;189:114285. doi: 10.1016/j.bcp.2020.114285. Epub 2020 Oct 15.
3
Therapeutic and Mechanistic Perspectives of Protein Complexes in Breast Cancer.
乳腺癌中蛋白质复合物的治疗及作用机制展望
Front Cell Dev Biol. 2019 Dec 20;7:335. doi: 10.3389/fcell.2019.00335. eCollection 2019.
4
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
5
Silencing of the long non-coding RNA RHPN1-AS1 suppresses the epithelial-to-mesenchymal transition and inhibits breast cancer progression.长链非编码RNA RHPN1-AS1的沉默抑制上皮-间质转化并抑制乳腺癌进展。
Am J Transl Res. 2019 Jun 15;11(6):3505-3517. eCollection 2019.
6
Nuclear Receptors: Recent Drug Discovery for Cancer Therapies.核受体:癌症治疗的最新药物发现。
Endocr Rev. 2019 Oct 1;40(5):1207-1249. doi: 10.1210/er.2018-00222.
7
Long noncoding RNA RUSC1‑AS‑N promotes cell proliferation and metastasis through Wnt/β‑catenin signaling in human breast cancer.长链非编码 RNA RUSC1-AS-N 通过 Wnt/β-连环蛋白信号通路促进人乳腺癌细胞的增殖和转移。
Mol Med Rep. 2019 Feb;19(2):861-868. doi: 10.3892/mmr.2018.9763. Epub 2018 Dec 14.
8
Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer.PIM1的下调调节糖酵解并抑制胆囊癌的肿瘤进展。
Cancer Manag Res. 2018 Oct 30;10:5101-5112. doi: 10.2147/CMAR.S184381. eCollection 2018.
9
Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.长链非编码 RNA Opa 相互作用蛋白 5-反义 RNA 1 的下调通过上调 microRNA-129-5p 靶向性别决定区 Y 盒 2 抑制乳腺癌进展。
Cancer Sci. 2019 Jan;110(1):289-302. doi: 10.1111/cas.13879. Epub 2018 Dec 13.
10
MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway.miR-126 通过 ATR/CHEK1 通路负调控 PLK-4 影响肝癌的发生发展。
Cell Death Dis. 2018 Oct 12;9(10):1045. doi: 10.1038/s41419-018-1020-0.